CCL3 and cancer: The authors showed that MAMs, mainly originated from circulating inflammatory monocytes (IMs), could interact with metastatic cells and activation of the CCL3–CCR1 axis promotes adhesion of macrophages to VCAM-1 (Vascular cell adhesion protein 1) expressing cancer cells through integrin α4 [22].